Merck became the second major pharma company to agree to a large settlement with the federal government this week. The company will reportedly pay $950 million to settle charges that it promoted painkiller Vioxx for an unapproved use.
Earlier this week, The Wall Street Journal reported that Pfizer will pay more than $60 million to resolve government investigations into whether it paid bribes to win foreign business.
